188 related articles for article (PubMed ID: 32314747)
1. Insulin-Like Growth Factor 1 (IGF1) Pathway Member Polymorphisms Are Associated with Risk and Prognosis of Chondrosarcoma.
Xie H; Mao JS; Hu WF
Med Sci Monit; 2020 Apr; 26():e923853. PubMed ID: 32314747
[TBL] [Abstract][Full Text] [Related]
2. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
[TBL] [Abstract][Full Text] [Related]
3. Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy.
Chang CF; Pao JB; Yu CC; Huang CY; Huang SP; Yang YP; Huang CN; Chang TY; You BJ; Lee HZ; Hour TC; Bao BY
Ann Surg Oncol; 2013 Jul; 20(7):2446-52. PubMed ID: 23397154
[TBL] [Abstract][Full Text] [Related]
4. Association of IGF1 and IGF1R gene polymorphisms with high myopia in a Han Chinese population.
Wang P; Liu X; Ye Z; Gong B; Yang Y; Zhang D; Wu X; Zheng H; Li Y; Yang Z; Shi Y
Ophthalmic Genet; 2017; 38(2):122-126. PubMed ID: 27044882
[TBL] [Abstract][Full Text] [Related]
5. Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls.
Chang HP; Yang SF; Wang SL; Su PH
BMC Endocr Disord; 2018 Sep; 18(1):66. PubMed ID: 30249230
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the IGF1 gene and their association with growth traits, serum concentration and expression rate of IGF1 and IGF1R in buffalo.
El-Magd MA; Saleh AA; Nafeaa AA; El-Komy SM; Afifi MA
J Zhejiang Univ Sci B; 2017 Dec.; 18(12):1064-1074. PubMed ID: 29204986
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
8. Maternal IGF1 and IGF1R polymorphisms and the risk of spontaneous preterm birth.
He JR; Lai YM; Liu HH; Liu GJ; Li WD; Fan XJ; Wei XL; Xia XY; Kuang YS; Liu XD; Chen NN; Lu JH; Chen QZ; Mai WB; Xia HM; Qiu X
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28213921
[TBL] [Abstract][Full Text] [Related]
9. Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women.
Qian B; Zheng H; Yu H; Chen K
Breast Cancer Res Treat; 2011 Nov; 130(1):217-26. PubMed ID: 21562710
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.
Pearce CL; Doherty JA; Van Den Berg DJ; Moysich K; Hsu C; Cushing-Haugen KL; Conti DV; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Pharoah PD; Song H; Kjaer SK; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Sieh W; Gronwald J; Medrek K; Jakubowska A; Lubinski J; Chenevix-Trench G; ; Beesley J; Webb PM; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Edlund CK; Stram DO; Pike MC; Ness RB; Rossing MA; Wu AH
Hum Mol Genet; 2011 Jun; 20(11):2263-72. PubMed ID: 21422097
[TBL] [Abstract][Full Text] [Related]
11. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ
Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074
[TBL] [Abstract][Full Text] [Related]
12. Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.
Winder T; Zhang W; Yang D; Ning Y; Bohanes P; Gerger A; Wilson PM; Pohl A; Mauro DJ; Langer C; Rowinsky EK; Lenz HJ
Clin Cancer Res; 2010 Nov; 16(22):5591-602. PubMed ID: 20935157
[TBL] [Abstract][Full Text] [Related]
13. A Possible Link of Genetic Variations in ER/IGF1R Pathway and Risk of Melanoma.
Yuan TA; Yourk V; Farhat A; Guo KL; Garcia A; Meyskens FL; Liu-Smith F
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150843
[TBL] [Abstract][Full Text] [Related]
14. Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in Korean women.
Kang HS; Ahn SH; Mishra SK; Hong KM; Lee ES; Shin KH; Ro J; Lee KS; Kim MK
PLoS One; 2014; 9(1):e84532. PubMed ID: 24392142
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
16. Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer.
Muendlein A; Lang AH; Geller-Rhomberg S; Winder T; Gasser K; Drexel H; Decker T; Mueller-Holzner E; Chamson M; Marth C; Hubalek M
J Cancer Res Clin Oncol; 2013 Mar; 139(3):491-8. PubMed ID: 23180020
[TBL] [Abstract][Full Text] [Related]
17. Genetic Polymorphisms of Insulin-Like Growth Factor 1 Are Associated with Osteosarcoma Risk and Prognosis.
Mao J; Zhuang G; Chen Z
Med Sci Monit; 2017 Dec; 23():5892-5898. PubMed ID: 29232358
[TBL] [Abstract][Full Text] [Related]
18. Elevated insulin-like growth factor 2 expression may contribute to the hypermuscular phenotype of myostatin null mice.
Clark DL; Clark DI; Hogan EK; Kroscher KA; Dilger AC
Growth Horm IGF Res; 2015 Oct; 25(5):207-18. PubMed ID: 26198127
[TBL] [Abstract][Full Text] [Related]
19. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y
J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.
Keku TO; Vidal A; Oliver S; Hoyo C; Hall IJ; Omofoye O; McDoom M; Worley K; Galanko J; Sandler RS; Millikan R
Cancer Causes Control; 2012 Jul; 23(7):1127-38. PubMed ID: 22565227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
